JP Patent

JP5896991B2 — 置換された５−フルオロ−１ｈ−ピラゾロピリジン及びそれらの使用

Assigned to アドヴェリオ・ファーマ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング · Expires 2016-03-30 · 10y expired

What this patent protects

Patent listed against Verquvo.

Drugs covered by this patent

Patent Metadata

Patent number
JP5896991B2
Jurisdiction
JP
Classification
—
Expires
2016-03-30
Drug substance claim
No
Drug product claim
No
Assignee
アドヴェリオ・ファーマ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.